475 results on '"Katona, Bryson W."'
Search Results
2. Low prevalence of gastric intestinal metaplasia and Helicobacter pylori on surveillance upper endoscopy in Lynch syndrome
3. Combining clinical and molecular characterization of CDH1: a multidisciplinary approach to reclassification of a splicing variant
4. Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment
5. Comparing telemedicine and in-person gastrointestinal cancer genetic appointment outcomes during the COVID-19 pandemic
6. Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
7. Preventive strategies in familial and hereditary colorectal cancer
8. Exploring Stakeholdersʼ Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey
9. Outcomes of the IMMray PanCan-d Test in High-Risk Individuals Undergoing Pancreatic Surveillance: Pragmatic Data and Lessons Learned
10. Outcomes of upper endoscopy screening in Lynch syndrome: a meta-analysis
11. “PMS2CL interference leading to erroneous identification of a pathogenic PMS2 variant in Black Patients”
12. Gastroenteropancreatic Neuroendocrine Tumors
13. β-Hydroxybutyrate suppresses colorectal cancer
14. Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
15. Menin in Cancer.
16. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.
17. Evaluation of Classic, Attenuated, and Oligopolyposis of the Colon
18. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals
19. CAR T cells targeting CD13 controllably induce eradication of acute myeloid leukemia with a single domain antibody switch
20. Clinical Management of Oligopolyposis of Unknown Etiology
21. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals.
22. Endoscopic Ultrasound Has Limited Utility in Diagnosis of Gastric Cancer in Carriers of CDH1 Mutations
23. Real-world 177Lu-DOTATATE peptide receptor radionuclide therapy: Treatment outcomes with dosing variations and in non-midgut neuroendocrine tumors.
24. Assessment of the Psychosocial Impact of Pancreatic Cancer Surveillance in High-Risk Individuals
25. Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer
26. Genetic testing for hereditary gastrointestinal cancer syndromes: Interpreting results in today's practice
27. Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer
28. Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening
29. Rebranding Colonic Polyposis of Unknown Etiology
30. Less is more: rethinking colorectal cancer resection strategies in Lynch syndrome
31. Supplementary Table 1 from Rates of Intervention and Cancer Detection on Initial versus Subsequent Whole-body MRI Screening in Li-Fraumeni Syndrome
32. Data from Rates of Intervention and Cancer Detection on Initial versus Subsequent Whole-body MRI Screening in Li-Fraumeni Syndrome
33. Supplementary Table 2 from Rates of Intervention and Cancer Detection on Initial versus Subsequent Whole-body MRI Screening in Li-Fraumeni Syndrome
34. Approach to upper gastrointestinal tract lesions in familial adenomatous polyposis
35. Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation
36. Identification of a novel GREM1 duplication in a patient with multiple colon polyps
37. Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants
38. APCandP53mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer
39. Menin Maintains Cholesterol Content in Colorectal Cancer via Repression of LXR-Mediated Transcription
40. Rates of Intervention and Cancer Detection on Initial versus Subsequent Whole-body MRI Screening in Li-Fraumeni Syndrome
41. Non-targeted biopsies in hereditary diffuse gastric cancer: Necessary, but not enough
42. Supplementary Table 4 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
43. Supplementary Table 2 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
44. Supplementary Table 3 from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
45. Data from Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
46. Gastric Cancer Genomics: Advances and Future Directions
47. Real-world 177 Lu-DOTATATE peptide receptor radionuclide therapy: Treatment outcomes with dosing variations and in non-midgut neuroendocrine tumors.
48. Prediction of 177 Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on 68 Ga-DOTATATE PET/CT.
49. Assessment of the Psychosocial Impact of Pancreatic Cancer Surveillance in High-Risk Individuals.
50. PMS2CL interference leading to erroneous identification of a pathogenic PMS2 variant in Black patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.